For research assistance [email protected] or +1 212 564 2838
My Account Register
LeadingMarketResearch.com
  • Home
  • About Us
  • Client Services
  • Our Clients
  • Database
  • Partners
  • Contact
  • All Industries
    Markets
  • Diagnostics
    Medical Devices
  • Pharmaceuticals
    Biotechnology
  • Chemicals
    Materials
  • Consumer
    Goods
  • Food
    Beverage
  • Telecom
    Electronics
  • Companies
  • Countries
  • Advanced Search
Home Pharmaceuticals, Biotechnology Pharmaceuticals Therapeutic Areas Schizophrenia

Schizophrenia Market Research Reports

To refine your search by industry, market, geographic region, country or price, use Advanced Search or contact Client Services for assistance.

  • Report Title Set Descending Direction
    Published Set Ascending Direction
    Price Set Descending Direction
  • Schizophrenia - Market Insights, Epidemiology and Market Forecast - 2030
    October 1, 2020
    $8,550.00
  • Schizophrenia Global Clinical Trials Review, H1, 2020
    January 15, 2020
    $2,500.00
  • Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019
    February 1, 2019
    $2,000.00
  • Schizophrenia - Pipeline Review, H2 2018
    October 30, 2018
    $2,000.00
  • Global Schizophrenia Partnering 2010 to 2017
    November 1, 2017
    $1,495.00
  • Schizophrenia - Current and Future Players
    November 1, 2016
    $2,995.00
  • Schizophrenia - US Drug Forecast and Market Analysis to 2025
    November 1, 2016
    $4,995.00
  • Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025
    November 1, 2016
    $6,995.00
  • Schizophrenia - Japan Drug Forecast and Market Analysis to 2025
    November 1, 2016
    $4,995.00
  • Schizophrenia - Market Insights, Epidemiology and Market Forecast-2023
    August 1, 2016
    $4,950.00
  • Schizoaffective Disorder Global Clinical Trials Review, H2, 2016
    July 27, 2016
    $2,500.00
  • Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016
    July 20, 2016
    $2,000.00
  • Frontier Pharma: Schizophrenia and Associated Indications - Small but Diverse Range of First-in-Class Molecular Targets Hold Promise for Treatment of Negative and Cognitive Symptoms
    April 1, 2016
    $6,995.00


Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

[email protected]
+1 212 564 2838

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

[email protected]
+1 212 564 2838

Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838

Browse All Reports

  • Advertising
  • Aerospace, Defense
  • Automotive
  • Banking
  • Biotechnology
  • Business Services
  • Chemicals
  • Company Reports
  • Construction
  • Consumer Goods
  • Countries
  • Diagnostics
  • Energy, Environment
  • Food & Beverages
  • Government
  • Healthcare
  • IT
  • Manufacturing
  • Media
  • Medical Devices
  • Pharmaceuticals
  • Retailing
  • Sales & Marketing
  • Sourcing
  • Telecommunications
  • Transportation
  • Travel, Entertainment

© LeadingMarketResearch.com. All rights reserved.

Privacy Policy Terms & Conditions